Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study

This publication has 10 references indexed in Scilit:

• Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex
  Brain Research, 1992
• Effects of monoamine uptake inhibitors on extracellular and platelet 5‐hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine
  British Journal of Pharmacology, 1992
• EFFECTS OF MAO INHIBITORS ON EXTRACELLULAR SEROTONIN IN THE RAPHE NUCLEI AND FRONTAL CORTEX. AN IN VIVO MICRODIALYSIS STUDY IN THE AWAKE RAT.
  Clinical Neuropharmacology, 1992
• Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1991
• Direct Immunohistochemical Evidence of the Existence of 5‐HT_1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei
  European Journal of Neuroscience, 1990
• Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis
  Neuroscience Letters, 1989
• 5‐HT₁ agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis
  British Journal of Pharmacology, 1989
• Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT_1A and 5‐HT_1B agonists
  Synapse, 1987
• Review of the animal pharmacology and pharmacokinetics of fluvoxamine.
  British Journal of Clinical Pharmacology, 1983
• FLUVOXAMINE, A SPECIFIC 5‐HYDROXYTRYPTAMINE UPTAKE INHIBITOR
  British Journal of Pharmacology, 1977